Journal
CLINICAL TRIALS
Volume 19, Issue 1, Pages 107-111Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/17407745211051279
Keywords
data monitoring committee; interim statistical reports
Categories
Ask authors/readers for more resources
Current Data Monitoring Committee Reports lack the necessary information for informed decision-making on risks and benefits; urgent and serious improvements are needed for Data Monitoring Committees to fulfill their ethical, clinical, and scientific responsibilities; all parties involved in the Data Monitoring Committee process should have a better understanding of its structure, function, and needs.
Currently, too many Data Monitoring Committee Reports for interim review of trial progress are quite inadequate for Data Monitoring Committees to make informed decisions about risks and benefits. Immediate serious improvement is necessary for Data Monitoring Committees to meet their ethical, clinical, and scientific responsibility to trial participants, investigators, sponsors, and participating institutions. To achieve this critical goal, all parties involved in the Data Monitoring Committee process including sponsors, investigators, Data Monitoring Committee members, and the independent statistical reporting group need to have a better understanding of the structure, function, and needs of a Data Monitoring Committee and the content of a Data Monitoring Committee Report. Training modules through the Society for Clinical Trials are now available on their website to facilitate this.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available